-
2
-
-
84910467774
-
Diffuse pleural mesothelioma in the Northwestern Cape Province
-
Wagner J.C., Sleggs C.A., Merchand P. Diffuse pleural mesothelioma in the Northwestern Cape Province. Br. J. Ind. Med. 17:1960;260-271.
-
(1960)
Br. J. Ind. Med.
, vol.17
, pp. 260-271
-
-
Wagner, J.C.1
Sleggs, C.A.2
Merchand, P.3
-
3
-
-
0018650776
-
Mortality among shipyard workers in Genoa, Italy
-
Puntoni R., Vercelli M., Merlo F., Valerio F., Santi L. Mortality among shipyard workers in Genoa, Italy. Ann. N. Y. Acad. Sci. 330:1979;353-377.
-
(1979)
Ann. N. Y. Acad. Sci.
, vol.330
, pp. 353-377
-
-
Puntoni, R.1
Vercelli, M.2
Merlo, F.3
Valerio, F.4
Santi, L.5
-
4
-
-
0023886306
-
Biological markers in epidemiologic research
-
Hulka B.S., Wilcosky T. Biological markers in epidemiologic research. Arch. Environ. Health. 43:1988;83-89.
-
(1988)
Arch. Environ. Health
, vol.43
, pp. 83-89
-
-
Hulka, B.S.1
Wilcosky, T.2
-
5
-
-
0027083110
-
Molecular epidemiology in cancer risk. Assessment and prevention: Recent progress and avenues for future research
-
Wogan G.N. Molecular epidemiology in cancer risk. Assessment and prevention: recent progress and avenues for future research. Environ. Health Perspect. 98:1992;167-178.
-
(1992)
Environ. Health Perspect.
, vol.98
, pp. 167-178
-
-
Wogan, G.N.1
-
6
-
-
0034817293
-
A historical cohort mortality study among shipyard workers in Genova, Italy
-
Puntoni R., Merlo F., Borsa L., Reggiardo G., Garrone E., Ceppi M. A historical cohort mortality study among shipyard workers in Genova, Italy. Am. J. Ind. Med. 40:2001;363-370.
-
(2001)
Am. J. Ind. Med.
, vol.40
, pp. 363-370
-
-
Puntoni, R.1
Merlo, F.2
Borsa, L.3
Reggiardo, G.4
Garrone, E.5
Ceppi, M.6
-
7
-
-
0030740850
-
Latency periods in asbestos-related mesothelioma of the pleura
-
Bianchi C., Giarelli L., Grandi G., Brollo A., Ramani L., Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur. J. Cancer Prev. 6:1997;162-166.
-
(1997)
Eur. J. Cancer Prev.
, vol.6
, pp. 162-166
-
-
Bianchi, C.1
Giarelli, L.2
Grandi, G.3
Brollo, A.4
Ramani, L.5
Zuch, C.6
-
8
-
-
0028840381
-
Genetic factors in the aetiology of malignant mesothelioma
-
Huncharek M. Genetic factors in the aetiology of malignant mesothelioma. Eur. J. Cancer. 31A:1995;1741-1747.
-
(1995)
Eur. J. Cancer
, vol.31 A
, pp. 1741-1747
-
-
Huncharek, M.1
-
9
-
-
0031218470
-
Oncogenes and tumor-suppressor genes in mesothelioma: A synopsis
-
Lechner J.F., Tesfaiqzi J., Gerwin B.I. Oncogenes and tumor-suppressor genes in mesothelioma: a synopsis. Environ. Health Perspect. 105:1997;1061-1067.
-
(1997)
Environ. Health Perspect.
, vol.105
, pp. 1061-1067
-
-
Lechner, J.F.1
Tesfaiqzi, J.2
Gerwin, B.I.3
-
10
-
-
0014531281
-
Xeroderma pigmentosum: A human disease in which an initial stage of DNA repair is defective
-
Cleaver J.E. Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc. Natl. Acad Sci. 63:1969;428-435.
-
(1969)
Proc. Natl. Acad Sci.
, vol.63
, pp. 428-435
-
-
Cleaver, J.E.1
-
11
-
-
0037445248
-
Role of DNA mismatch repair defects in the pathogenesis of human cancer
-
Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 21:2003;1174-1179.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 1174-1179
-
-
Peltomaki, P.1
-
12
-
-
0026768777
-
Use of mesothelial cell cultures to assess the carcinogenic potency of mineral or man made fibers
-
Renier A., Yegles M., Buard A., Dong H., Kheuang L., Saint-Etienne L., Laurent P., Jaurand M.C. Use of mesothelial cell cultures to assess the carcinogenic potency of mineral or man made fibers. Cell. Biol. Toxicol. 8:1992;133-139.
-
(1992)
Cell. Biol. Toxicol.
, vol.8
, pp. 133-139
-
-
Renier, A.1
Yegles, M.2
Buard, A.3
Dong, H.4
Kheuang, L.5
Saint-Etienne, L.6
Laurent, P.7
Jaurand, M.C.8
-
13
-
-
0032913470
-
DNA single strand breaks induced by asbestos fibers in human pleural mesothelial cells in vitro
-
Ollikainen T., Linnainmaa K., Kinnula V.L. DNA single strand breaks induced by asbestos fibers in human pleural mesothelial cells in vitro. Environ. Mol. Mutagen. 33:1999;153-160.
-
(1999)
Environ. Mol. Mutagen.
, vol.33
, pp. 153-160
-
-
Ollikainen, T.1
Linnainmaa, K.2
Kinnula, V.L.3
-
14
-
-
0033556432
-
Asbestos and DNA double strand breaks
-
Okayasu R., Takahashi S., Yamada S., Hei T.K., Ullrich R.L. Asbestos and DNA double strand breaks. Cancer Res. 59:1999;298-300.
-
(1999)
Cancer Res.
, vol.59
, pp. 298-300
-
-
Okayasu, R.1
Takahashi, S.2
Yamada, S.3
Hei, T.K.4
Ullrich, R.L.5
-
15
-
-
0033823647
-
Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells
-
Liu W., Ernst J.D., Courtney Broaddus V. Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am. J. Respir. Cell. Mol. Biol. 23:2000;371-378.
-
(2000)
Am. J. Respir. Cell. Mol. Biol.
, vol.23
, pp. 371-378
-
-
Liu, W.1
Ernst, J.D.2
Courtney Broaddus, V.3
-
16
-
-
0037173717
-
SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11
-
Digweed M., Demuth I., Rothe S., Scholz R., Jordan A., Grotzinger C., Schindler D., Grompe M., Sperling K. SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11. Oncogene. 21:2002;4873-4878.
-
(2002)
Oncogene
, vol.21
, pp. 4873-4878
-
-
Digweed, M.1
Demuth, I.2
Rothe, S.3
Scholz, R.4
Jordan, A.5
Grotzinger, C.6
Schindler, D.7
Grompe, M.8
Sperling, K.9
-
17
-
-
0033779869
-
Reduced global genomic repair of ultraviolet light-induced cyclobutane pyrimidine dimers in simian virus 40-transformed human cells
-
Bowman K.K., Sicard D.M., Ford J.M., Hanawalt P.C. Reduced global genomic repair of ultraviolet light-induced cyclobutane pyrimidine dimers in simian virus 40-transformed human cells. Mol. Carcinog. 29:2000;17-24.
-
(2000)
Mol. Carcinog.
, vol.29
, pp. 17-24
-
-
Bowman, K.K.1
Sicard, D.M.2
Ford, J.M.3
Hanawalt, P.C.4
-
18
-
-
0034616662
-
Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review
-
Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 92:2000;874-897.
-
(2000)
J. Natl. Cancer Inst.
, vol.92
, pp. 874-897
-
-
Berwick, M.1
Vineis, P.2
-
19
-
-
0036790035
-
High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural mesothelioma
-
Bolognesi C., Filiberti R., Neri M., Perrone E., Landini E., Canessa P.A., Simonassi C., Cerrano P.G., Mutti L., Puntoni R. High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural mesothelioma. Cancer Res. 62:2002;5418-5419.
-
(2002)
Cancer Res.
, vol.62
, pp. 5418-5419
-
-
Bolognesi, C.1
Filiberti, R.2
Neri, M.3
Perrone, E.4
Landini, E.5
Canessa, P.A.6
Simonassi, C.7
Cerrano, P.G.8
Mutti, L.9
Puntoni, R.10
-
20
-
-
0034693730
-
The in vitro micronucleus technique
-
Fenech M. The in vitro micronucleus technique. Mutat. Res. 455:2000;81-95.
-
(2000)
Mutat. Res.
, vol.455
, pp. 81-95
-
-
Fenech, M.1
-
21
-
-
0035140477
-
Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis in single-cell gell electrophoresis
-
Maluf S.W., Erdtmann B. Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis in single-cell gell electrophoresis. Cancer Genet. Cytogenet. 124:2001;71-75.
-
(2001)
Cancer Genet. Cytogenet.
, vol.124
, pp. 71-75
-
-
Maluf, S.W.1
Erdtmann, B.2
-
22
-
-
0037139239
-
Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation
-
Trenz K., Rothfuss A., Schutz P., Speit G. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat. Res. 500:2002;89-96.
-
(2002)
Mutat. Res.
, vol.500
, pp. 89-96
-
-
Trenz, K.1
Rothfuss, A.2
Schutz, P.3
Speit, G.4
-
23
-
-
0020345354
-
Carcinogen-metabolizing enzymes and susceptibility to chemical carcinogenesis
-
Bartsch H., Aitio A., Camus A.M., Malaveille C., Ohshima H., Pignatelli B., Sabadie N. Carcinogen-metabolizing enzymes and susceptibility to chemical carcinogenesis. IARC Sci. Publ. 39:1982;337-350.
-
(1982)
IARC Sci. Publ.
, vol.39
, pp. 337-350
-
-
Bartsch, H.1
Aitio, A.2
Camus, A.M.3
Malaveille, C.4
Ohshima, H.5
Pignatelli, B.6
Sabadie, N.7
-
24
-
-
0021652014
-
Genetic susceptibility to toxic substances and its relationship to carcinogenesis
-
Hanke J.Z. Genetic susceptibility to toxic substances and its relationship to carcinogenesis. IARC Sci. Publ. 59:1984;99-106.
-
(1984)
IARC Sci. Publ.
, vol.59
, pp. 99-106
-
-
Hanke, J.Z.1
-
25
-
-
0033057603
-
The molecular basis of asbestos induced lung injury
-
Kamp D.W., Weitzman S.A. The molecular basis of asbestos induced lung injury. Thorax. 54:1999;638-652.
-
(1999)
Thorax
, vol.54
, pp. 638-652
-
-
Kamp, D.W.1
Weitzman, S.A.2
-
26
-
-
0027998336
-
Inherited glutathione S-transferase deficiency is a risk factor for pulmonary asbestosis
-
Smith C.M., Kelsey K.T., Wiencke J.K., Leyden K., Stephen L., Christiani D.C. Inherited glutathione S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol. Biomarkers Prev. 3:1994;471-477.
-
(1994)
Cancer Epidemiol. Biomarkers Prev.
, vol.3
, pp. 471-477
-
-
Smith, C.M.1
Kelsey, K.T.2
Wiencke, J.K.3
Leyden, K.4
Stephen, L.5
Christiani, D.C.6
-
27
-
-
0030451114
-
Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders
-
Hirvonen A., Saarikoski S.T., Linnainmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst. 88:1996;1853-1856.
-
(1996)
J. Natl. Cancer Inst.
, vol.88
, pp. 1853-1856
-
-
Hirvonen, A.1
Saarikoski, S.T.2
Linnainmaa, K.3
Koskinen, K.4
Husgafvel-Pursiainen, K.5
Mattson, K.6
Vainio, H.7
-
28
-
-
0035667408
-
Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis
-
Stucker I., Boffetta P., Antilla S., Benhamou S., Hirvonen A., London S., Taioli E. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 10:2001;1253-1258.
-
(2001)
Cancer Epidemiol. Biomarkers Prev.
, vol.10
, pp. 1253-1258
-
-
Stucker, I.1
Boffetta, P.2
Antilla, S.3
Benhamou, S.4
Hirvonen, A.5
London, S.6
Taioli, E.7
-
29
-
-
0029032229
-
Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma
-
Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res. 55:1995;2981-2983.
-
(1995)
Cancer Res.
, vol.55
, pp. 2981-2983
-
-
Hirvonen, A.1
Pelin, K.2
Tammilehto, L.3
Karjalainen, A.4
Mattson, K.5
Linnainmaa, K.6
-
30
-
-
0344759080
-
Metabolic gene polymorphism frequencies in pleural malignant mesothelioma
-
Neri M., Gaspari L., Filiberti R., Ivaldi G.P., Canessa P., Mereu C., Garte S., Puntoni R., Taioli E. Metabolic gene polymorphism frequencies in pleural malignant mesothelioma. Proc. AACR. 43:2002;775.
-
(2002)
Proc. AACR
, vol.43
, pp. 775
-
-
Neri, M.1
Gaspari, L.2
Filiberti, R.3
Ivaldi, G.P.4
Canessa, P.5
Mereu, C.6
Garte, S.7
Puntoni, R.8
Taioli, E.9
-
31
-
-
0034284765
-
Differential gene expression in mesothelioma
-
Rihn H., Mohr S., McDowell S.A., Binet S., Loubinoux J., Galateau F., Keith G., Leikauf G.D. Differential gene expression in mesothelioma. FEBS Lett. 480:2000;95-100.
-
(2000)
FEBS Lett.
, vol.480
, pp. 95-100
-
-
Rihn, H.1
Mohr, S.2
Mcdowell, S.A.3
Binet, S.4
Loubinoux, J.5
Galateau, F.6
Keith, G.7
Leikauf, G.D.8
-
32
-
-
0035332369
-
DNA copy number changes in familial malignant mesothelioma
-
Ascoli A., Aalto Y., Carnovale-Scalzo C., Nardi F., Falzetti D., Mecucci C., Knuutila S. DNA copy number changes in familial malignant mesothelioma. Cancer Genet. Cytogenet. 127:2001;80-82.
-
(2001)
Cancer Genet. Cytogenet.
, vol.127
, pp. 80-82
-
-
Ascoli, A.1
Aalto, Y.2
Carnovale-Scalzo, C.3
Nardi, F.4
Falzetti, D.5
Mecucci, C.6
Knuutila, S.7
-
33
-
-
0035866041
-
Gene expression profiling of malignant mesothelioma cell lines: CDNA array study
-
Kettunen E., Nissen A.M., Ollikainen T., Taavitsainen M., Tapper J., Linnainmaa K., Knuutila S., El-Rifai W. Gene expression profiling of malignant mesothelioma cell lines: cDNA array study. Int. J. Cancer. 91:2001;492-496.
-
(2001)
Int. J. Cancer
, vol.91
, pp. 492-496
-
-
Kettunen, E.1
Nissen, A.M.2
Ollikainen, T.3
Taavitsainen, M.4
Tapper, J.5
Linnainmaa, K.6
Knuutila, S.7
El-Rifai, W.8
-
34
-
-
0028888765
-
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma
-
Amin K.M., Litzky L.A., Smythe W.R., Mooney A.M., Morris J.M., Mews D.J., Pass H.I., Kari C., Rodeck U., Rauscher F.J. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am. J. Pathol. 146:1995;344-356.
-
(1995)
Am. J. Pathol.
, vol.146
, pp. 344-356
-
-
Amin, K.M.1
Litzky, L.A.2
Smythe, W.R.3
Mooney, A.M.4
Morris, J.M.5
Mews, D.J.6
Pass, H.I.7
Kari, C.8
Rodeck, U.9
Rauscher, F.J.10
-
35
-
-
0037171681
-
The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma
-
Hecht J.L., Lee B.H., Pinkus J.L., Pinkus G.S. The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma. Cancer. 96:2002;105-109.
-
(2002)
Cancer
, vol.96
, pp. 105-109
-
-
Hecht, J.L.1
Lee, B.H.2
Pinkus, J.L.3
Pinkus, G.S.4
-
36
-
-
0030801959
-
Biomarkers of gene expression: Growth factors and oncoproteins
-
Brandt-Rauf P.W. Biomarkers of gene expression: growth factors and oncoproteins. Environ. Health Perspect. 105(Suppl. 4):1997;807-816.
-
(1997)
Environ. Health Perspect.
, vol.105
, Issue.SUPPL. 4
, pp. 807-816
-
-
Brandt-Rauf, P.W.1
-
37
-
-
0028222828
-
Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans
-
Brandt-Rauf P.W., Luo J.C., Carney W.P., Smith S., De Vivo I., Milling C., Hemminki K., Koskinen H., Vainio H., Neugut A.I. Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans. Int. J. Cancer. 56:1994;383-386.
-
(1994)
Int. J. Cancer
, vol.56
, pp. 383-386
-
-
Brandt-Rauf, P.W.1
Luo, J.C.2
Carney, W.P.3
Smith, S.4
De Vivo, I.5
Milling, C.6
Hemminki, K.7
Koskinen, H.8
Vainio, H.9
Neugut, A.I.10
-
38
-
-
0032942372
-
Increased serum concentration of growth factor receptors and Neu in workers previously exposed to asbestos
-
Lahat N., Froom P., Kristal-Boneh E., Lahat N., Froom P., Cohen C., Lerman Y., Ribakl J. Increased serum concentration of growth factor receptors and Neu in workers previously exposed to asbestos. Occup. Environ. Med. 56:1999;114-117.
-
(1999)
Occup. Environ. Med.
, vol.56
, pp. 114-117
-
-
Lahat, N.1
Froom, P.2
Kristal-Boneh, E.3
Lahat, N.4
Froom, P.5
Cohen, C.6
Lerman, Y.7
Ribakl, J.8
-
39
-
-
0026523003
-
Serum oncoproteins and growth factors in asbestosis and silicosis patients
-
Brandt-Rauf P.W., Smith S., Hemminki K., Koskinen H., Vainio H., Niman H., Ford J. Serum oncoproteins and growth factors in asbestosis and silicosis patients. Int. J. Cancer. 50:1992;881-885.
-
(1992)
Int. J. Cancer
, vol.50
, pp. 881-885
-
-
Brandt-Rauf, P.W.1
Smith, S.2
Hemminki, K.3
Koskinen, H.4
Vainio, H.5
Niman, H.6
Ford, J.7
-
40
-
-
0034933396
-
P53 p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: Correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure
-
Isik R R., Metintas M., Gibbs A.R., Metintas S., Jasani B., Oner U., Harmanci E., Demircan S., Isiksoy S. p53 p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure. Respir. Med. 95:2001;588-593.
-
(2001)
Respir. Med.
, vol.95
, pp. 588-593
-
-
Isik, R.R.1
Metintas, M.2
Gibbs, A.R.3
Metintas, S.4
Jasani, B.5
Oner, U.6
Harmanci, E.7
Demircan, S.8
Isiksoy, S.9
-
41
-
-
0028786922
-
Molecular biology studies on mesothelioma tumor samples: Preliminary data on H-ras, p21, and SV40
-
Cristaudo A., Vivaldi A., Sensales G., Guglielmi G., Ciancia E., Elisei R. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40. J. Environ. Pathol. Toxicol. Oncol. 14:1995;29-34.
-
(1995)
J. Environ. Pathol. Toxicol. Oncol.
, vol.14
, pp. 29-34
-
-
Cristaudo, A.1
Vivaldi, A.2
Sensales, G.3
Guglielmi, G.4
Ciancia, E.5
Elisei, R.6
-
42
-
-
0034702353
-
Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos
-
Ni Z., Liu Y., Keshava N., Zhou G., Whong W., Ong T. Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos. Mutat Res. 468:2000;87-92.
-
(2000)
Mutat Res.
, vol.468
, pp. 87-92
-
-
Ni, Z.1
Liu, Y.2
Keshava, N.3
Zhou, G.4
Whong, W.5
Ong, T.6
-
43
-
-
0032615070
-
Somatic genetic alterations in human malignant mesothelioma
-
(review)
-
Lee W.C., Testa J.R. Somatic genetic alterations in human malignant mesothelioma. Int. J. Oncol. 14:1999;181-188. (review).
-
(1999)
Int. J. Oncol.
, vol.14
, pp. 181-188
-
-
Lee, W.C.1
Testa, J.R.2
-
44
-
-
0032543305
-
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression
-
Frizelle S.P., Grim J., Zhou J., Gupta P., Curiel D.T., Geradts J., Kratzk R.A. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene. 16:1998;3087-3095.
-
(1998)
Oncogene
, vol.16
, pp. 3087-3095
-
-
Frizelle, S.P.1
Grim, J.2
Zhou, J.3
Gupta, P.4
Curiel, D.T.5
Geradts, J.6
Kratzk, R.A.7
-
45
-
-
0035258783
-
Mutational analysis of N-ras p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas
-
Papp T., Schipper H., Pemsel H., Bastrop R., Muller K.M., Wiethege T., Weiss D.G., Dopp E., Schiffmann D., Rahman Q. Mutational analysis of N-ras p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas. Int. J. Oncol. 18:2003;425-433.
-
(2003)
Int. J. Oncol.
, vol.18
, pp. 425-433
-
-
Papp, T.1
Schipper, H.2
Pemsel, H.3
Bastrop, R.4
Muller, K.M.5
Wiethege, T.6
Weiss, D.G.7
Dopp, E.8
Schiffmann, D.9
Rahman, Q.10
-
46
-
-
0029155471
-
Codeletion of p15 and p16 in primary malignant mesothelioma
-
Xio S., Li D., Vijg J., Sugarbaker D.J., Corson J.M., Fletcher J.A. Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene. 11:1995;511-515.
-
(1995)
Oncogene
, vol.11
, pp. 511-515
-
-
Xio, S.1
Li, D.2
Vijg, J.3
Sugarbaker, D.J.4
Corson, J.M.5
Fletcher, J.A.6
-
47
-
-
0037465584
-
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions
-
Illei P.B., Ladanyi M., Rusch V.W., Zakowski M.F. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 99:2003;51-56.
-
(2003)
Cancer
, vol.99
, pp. 51-56
-
-
Illei, P.B.1
Ladanyi, M.2
Rusch, V.W.3
Zakowski, M.F.4
-
48
-
-
0028971496
-
Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma
-
Kratzke R.A., Otterson G.A., Lincoln C.E., Ewing S., Oie H., Geradts J., Kaye F.J. Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. J. Natl. Cancer Inst. 87:1995;1870-1875.
-
(1995)
J. Natl. Cancer Inst.
, vol.87
, pp. 1870-1875
-
-
Kratzke, R.A.1
Otterson, G.A.2
Lincoln, C.E.3
Ewing, S.4
Oie, H.5
Geradts, J.6
Kaye, F.J.7
-
49
-
-
0036837992
-
Inactivation of p16(INK4a) expression in malignant mesothelioma by methylation
-
Wong L., Zhou J., Anderson D., Kratzke R.A. Inactivation of p16(INK4a) expression in malignant mesothelioma by methylation. Lung Cancer. 38:2002;131-136.
-
(2002)
Lung Cancer
, vol.38
, pp. 131-136
-
-
Wong, L.1
Zhou, J.2
Anderson, D.3
Kratzke, R.A.4
-
50
-
-
0029014010
-
Serum p53 antibodies as early markers of lung cancer
-
Lubin R., Zalcman G., Bouchet L., Tredanel J., Legros Y., Cazals D., Hirsch A., Soussi T. Serum p53 antibodies as early markers of lung cancer. Nat. Med. 1:1995;701-702.
-
(1995)
Nat. Med.
, vol.1
, pp. 701-702
-
-
Lubin, R.1
Zalcman, G.2
Bouchet, L.3
Tredanel, J.4
Legros, Y.5
Cazals, D.6
Hirsch, A.7
Soussi, T.8
-
51
-
-
0034688182
-
Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer
-
Zalcman G., Tredaniel J., Schlichtholz B., Urban T., Milleron B., Lubin R., Meignin V., Couderc L.J., Hirsch A., Soussi T. Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer. Int. J. Cancer (Pred. Oncol.). 89:2000;81-86.
-
(2000)
Int. J. Cancer (Pred. Oncol.)
, vol.89
, pp. 81-86
-
-
Zalcman, G.1
Tredaniel, J.2
Schlichtholz, B.3
Urban, T.4
Milleron, B.5
Lubin, R.6
Meignin, V.7
Couderc, L.J.8
Hirsch, A.9
Soussi, T.10
-
52
-
-
0035134987
-
P53 autoantibodies in patients with malignant mesothelioma: Stability through disease progression
-
Creaney J., McLaren B.M., Stevenson S., et al. p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression. Br. J. Cancer. 84:2001;52-56.
-
(2001)
Br. J. Cancer
, vol.84
, pp. 52-56
-
-
Creaney, J.1
Mclaren, B.M.2
Stevenson, S.3
-
53
-
-
0037312036
-
Serum anti-p53 autoantibodies in pleural malignant mesothelioma
-
Neri M., Betta P., Marroni P., Filiberti R., Cafferata M., Mereu C., Ivaldi G.P., Montanaro F., Puntoni R., Paganuzzi M. Serum anti-p53 autoantibodies in pleural malignant mesothelioma. Lung Cancer. 39:2003;165-172.
-
(2003)
Lung Cancer
, vol.39
, pp. 165-172
-
-
Neri, M.1
Betta, P.2
Marroni, P.3
Filiberti, R.4
Cafferata, M.5
Mereu, C.6
Ivaldi, G.P.7
Montanaro, F.8
Puntoni, R.9
Paganuzzi, M.10
-
54
-
-
0036178251
-
New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agents
-
Nowak A.K., Lake RA R.A., Kindler H.L., Robinson B.W. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin. Oncol. 29:2002;82-96.
-
(2002)
Semin. Oncol.
, vol.29
, pp. 82-96
-
-
Nowak, A.K.1
Lake Ra, R.A.2
Kindler, H.L.3
Robinson, B.W.4
-
55
-
-
0024314294
-
Oncogenes and their applications in epidemiologic studies
-
Taylor J.A. Oncogenes and their applications in epidemiologic studies. Am. J. Epidemiol. 130:1989;6-13.
-
(1989)
Am. J. Epidemiol.
, vol.130
, pp. 6-13
-
-
Taylor, J.A.1
-
56
-
-
0030041140
-
Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo
-
Langerak A.W., De Laat P.A., Van der Linden-Van Beurden C.A., Delahaye M., Van der Kwast T.H., Hoogsteden H.C., Benner R., Versnel M.A. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. J. Pathol. 178:1996;151-160.
-
(1996)
J. Pathol.
, vol.178
, pp. 151-160
-
-
Langerak, A.W.1
De Laat, P.A.2
Van Der Linden-Van Beurden, C.A.3
Delahaye, M.4
Van Der Kwast, T.H.5
Hoogsteden, H.C.6
Benner, R.7
Versnel, M.A.8
-
57
-
-
0029049328
-
Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions
-
Ascoli V., Scalzo C.C., Facciolo F., Nardi F. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions. Acta Cytol. 39:1995;613-622.
-
(1995)
Acta Cytol.
, vol.39
, pp. 613-622
-
-
Ascoli, V.1
Scalzo, C.C.2
Facciolo, F.3
Nardi, F.4
-
58
-
-
0034968904
-
Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo
-
Metheny-Barlow L.J., Flynn B., van Gijssel H.E., Marrogi A., Gerwin B.I. Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo. Am. J. Respir. Cell. Mol. Biol. 24:2001;694-702.
-
(2001)
Am. J. Respir. Cell. Mol. Biol.
, vol.24
, pp. 694-702
-
-
Metheny-Barlow, L.J.1
Flynn, B.2
Van Gijssel, H.E.3
Marrogi, A.4
Gerwin, B.I.5
-
59
-
-
0034039427
-
Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas
-
Thirkettle I., Harvey P., Hasleton P.S., Ball R.Y., Warn R.M. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology. 36:2000;522-528.
-
(2000)
Histopathology
, vol.36
, pp. 522-528
-
-
Thirkettle, I.1
Harvey, P.2
Hasleton, P.S.3
Ball, R.Y.4
Warn, R.M.5
-
60
-
-
0031852222
-
Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma
-
Tolnay E., Kuhnen C., Wiethege T., Konig J.E., Voss B., Muller K.M. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. J. Cancer Res. Clin. Oncol. 124:1998;291-296.
-
(1998)
J. Cancer Res. Clin. Oncol.
, vol.124
, pp. 291-296
-
-
Tolnay, E.1
Kuhnen, C.2
Wiethege, T.3
Konig, J.E.4
Voss, B.5
Muller, K.M.6
-
61
-
-
0030458008
-
Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas
-
Harvey P., Warn A., Newman P., Perry L.J., Ball R.Y., Warn R.M. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J. Pathol. 180:1996;389-394.
-
(1996)
J. Pathol.
, vol.180
, pp. 389-394
-
-
Harvey, P.1
Warn, A.2
Newman, P.3
Perry, L.J.4
Ball, R.Y.5
Warn, R.M.6
-
62
-
-
0036987136
-
Emerging insights into the biology and therapy of malignant mesothelioma
-
Vogelzang N.J. Emerging insights into the biology and therapy of malignant mesothelioma. Semin. Oncol. 29:2002;35-42.
-
(2002)
Semin. Oncol.
, vol.29
, pp. 35-42
-
-
Vogelzang, N.J.1
-
63
-
-
0028007620
-
Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway
-
Morocz I.A., Schmitter D., Lauber B., Stahel R.A. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway. Br. J. Cancer. 70:1994;850-856.
-
(1994)
Br. J. Cancer
, vol.70
, pp. 850-856
-
-
Morocz, I.A.1
Schmitter, D.2
Lauber, B.3
Stahel, R.A.4
-
64
-
-
0037105665
-
Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma
-
Janne P.A., Taffaro M.L., Salgia R., Johnson B.E. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Res. 15:2002;5242-5247.
-
(2002)
Cancer Res.
, vol.15
, pp. 5242-5247
-
-
Janne, P.A.1
Taffaro, M.L.2
Salgia, R.3
Johnson, B.E.4
-
65
-
-
0032452239
-
Determination of blood serum oncoprotein NEU and antioncoprotein p-53 - Molecular biomarkers in various types of occupational exposure
-
Krajewska B., Lutz W., Pilacik B. Determination of blood serum oncoprotein NEU and antioncoprotein p-53 - molecular biomarkers in various types of occupational exposure. Int J. Occup. Med. Environ. Health. 11:1998;343-348.
-
(1998)
Int J. Occup. Med. Environ. Health
, vol.11
, pp. 343-348
-
-
Krajewska, B.1
Lutz, W.2
Pilacik, B.3
-
66
-
-
0035476278
-
Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma
-
Ardizzoni A., Cafferata M.A., Paganuzzi M., Filiberti R., Marroni P., Neri M., Fontana V., Nicolo G., Perdelli L., Stampino C.G., Rosso R., Puntoni R. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma. Cancer. 82:2001;1896-1904.
-
(2001)
Cancer
, vol.82
, pp. 1896-1904
-
-
Ardizzoni, A.1
Cafferata, M.A.2
Paganuzzi, M.3
Filiberti, R.4
Marroni, P.5
Neri, M.6
Fontana, V.7
Nicolo, G.8
Perdelli, L.9
Stampino, C.G.10
Rosso, R.11
Puntoni, R.12
-
67
-
-
0031932619
-
Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers
-
Pache J.C., Janssen Y.M., Walsh E.S., Quinlan T.R., Zanella C.L., Low R.B., Taatjes D.J., Mossman B.T. Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am. J. Pathol. 152:1998;333-340.
-
(1998)
Am. J. Pathol.
, vol.152
, pp. 333-340
-
-
Pache, J.C.1
Janssen, Y.M.2
Walsh, E.S.3
Quinlan, T.R.4
Zanella, C.L.5
Low, R.B.6
Taatjes, D.J.7
Mossman, B.T.8
-
68
-
-
0035068834
-
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
-
Strizzi L., Catalano A., Vianale G., Orecchia S., Casalini A., Tassi G., Puntoni R., Mutti L., Procopio A. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J. Pathol. 193:2001;468-475.
-
(2001)
J. Pathol.
, vol.193
, pp. 468-475
-
-
Strizzi, L.1
Catalano, A.2
Vianale, G.3
Orecchia, S.4
Casalini, A.5
Tassi, G.6
Puntoni, R.7
Mutti, L.8
Procopio, A.9
-
69
-
-
0035349924
-
Basic fibroblast growth factor in mesothelioma pleural effusions: Correlation with patient survival and angiogenesis
-
Strizzi L., Vianale G., Catalano A., Muraro R., Mutti L L., Procopio A. Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis. Int. J. Oncol. 18:2001;1093-1098.
-
(2001)
Int. J. Oncol.
, vol.18
, pp. 1093-1098
-
-
Strizzi, L.1
Vianale, G.2
Catalano, A.3
Muraro, R.4
Mutti, L.L.5
Procopio, A.6
-
70
-
-
0037171944
-
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen
-
Catalano A., Romano M., Martinotti S., Procopio A. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Oncogene. 25:2002;2896-2900.
-
(2002)
Oncogene
, vol.25
, pp. 2896-2900
-
-
Catalano, A.1
Romano, M.2
Martinotti, S.3
Procopio, A.4
-
71
-
-
0037401047
-
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops
-
Masood R., Kundra A., Zhu S., Xia G., Scalia P P., Smith D.L., Gill P.S. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer. 104:2003;603-610.
-
(2003)
Int. J. Cancer
, vol.104
, pp. 603-610
-
-
Masood, R.1
Kundra, A.2
Zhu, S.3
Xia, G.4
Scalia, P.P.5
Smith, D.L.6
Gill, P.S.7
-
72
-
-
0037041269
-
Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders
-
Hirvonen A., Tuimala J., Ollikainen T., Linnainmaa K., Kinnula V. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Cancer Lett. 178:2002;71-74.
-
(2002)
Cancer Lett.
, vol.178
, pp. 71-74
-
-
Hirvonen, A.1
Tuimala, J.2
Ollikainen, T.3
Linnainmaa, K.4
Kinnula, V.5
-
73
-
-
0036216714
-
-
Baldi A., Groeger A.M., Esposito V., Cassandro R., Tonini G., Battista T., Di Marino M.P., Vincenzi B., Santini M., Angelini A., Rossiello R., Baldi F., Paggi M.G. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival thorax. 57:2002;353-356.
-
(2002)
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: Relationship with survival thorax
, vol.57
, pp. 353-356
-
-
Baldi, A.1
Groeger, A.M.2
Esposito, V.3
Cassandro, R.4
Tonini, G.5
Battista, T.6
Di Marino, M.P.7
Vincenzi, B.8
Santini, M.9
Angelini, A.10
Rossiello, R.11
Baldi, F.12
Paggi, M.G.13
-
74
-
-
0036006814
-
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
-
Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P.T., Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13:2002;41-59.
-
(2002)
Cytokine Growth Factor Rev.
, vol.13
, pp. 41-59
-
-
Maulik, G.1
Shrikhande, A.2
Kijima, T.3
Ma, P.C.4
Morrison, P.T.5
Salgia, R.6
-
75
-
-
0036803498
-
Cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly
-
Musti M., Cavone D., Aalto Y., Scattone A., Serio G., Knuutila S. Cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly. Cancer Genet. Cytogenet. 138:2002;73-76.
-
(2002)
Cancer Genet. Cytogenet.
, vol.138
, pp. 73-76
-
-
Musti, M.1
Cavone, D.2
Aalto, Y.3
Scattone, A.4
Serio, G.5
Knuutila, S.6
-
76
-
-
0035835437
-
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
-
Roushdy-Hammady I., Siegel J., Emri S., Testa J.R., Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 357:2001;444-445.
-
(2001)
Lancet
, vol.357
, pp. 444-445
-
-
Roushdy-Hammady, I.1
Siegel, J.2
Emri, S.3
Testa, J.R.4
Carbone, M.5
-
77
-
-
0032516719
-
Familial pleural malignant mesothelioma: Clustering in three sisters and one cousin
-
Ascoli V., Scalzo C.C., Bruno C., Facciolo F., Lopergolo M., Granone P., Nardi F. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett. 130:1998;203-207.
-
(1998)
Cancer Lett.
, vol.130
, pp. 203-207
-
-
Ascoli, V.1
Scalzo, C.C.2
Bruno, C.3
Facciolo, F.4
Lopergolo, M.5
Granone, P.6
Nardi, F.7
-
78
-
-
0032041885
-
Two familial mesothelioma cases with high concentrations of soluble cytokeratin 19 fragment in pleural fluid
-
Hiyama J., Marukawa M., Shiota Y., Ono T., Imai S., Motohiro K., Aoki J., Sasaki N., Taniyama K., Mashiba H. Two familial mesothelioma cases with high concentrations of soluble cytokeratin 19 fragment in pleural fluid. Intern. Med. 37:1998;407-410.
-
(1998)
Intern. Med.
, vol.37
, pp. 407-410
-
-
Hiyama, J.1
Marukawa, M.2
Shiota, Y.3
Ono, T.4
Imai, S.5
Motohiro, K.6
Aoki, J.7
Sasaki, N.8
Taniyama, K.9
Mashiba, H.10
-
79
-
-
0029873365
-
Parental cancer and genetic predisposition in malignant pleural mesothelioma: A case-control study
-
Huncharek M., Kelsey K., Muscat J., Christiani D. Parental cancer and genetic predisposition in malignant pleural mesothelioma: a case-control study. Cancer Lett. 102:1996;205-208.
-
(1996)
Cancer Lett.
, vol.102
, pp. 205-208
-
-
Huncharek, M.1
Kelsey, K.2
Muscat, J.3
Christiani, D.4
-
80
-
-
0030043985
-
Mesothelioma, asbestos, and reported history of cancer in first-degree relatives
-
Heineman E.F., Bernstein L., Stark A.D., Spirtas R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer. 77:1996;549-554.
-
(1996)
Cancer
, vol.77
, pp. 549-554
-
-
Heineman, E.F.1
Bernstein, L.2
Stark, A.D.3
Spirtas, R.4
-
82
-
-
0025103377
-
Malignant mesothelioma: Clustering in a family producing asbestos cement in their home
-
Otte K.E., Sigsgaard T.I., Kjaerulff J. Malignant mesothelioma: clustering in a family producing asbestos cement in their home. Br. J. Ind. Med. 47:1990;10-13.
-
(1990)
Br. J. Ind. Med.
, vol.47
, pp. 10-13
-
-
Otte, K.E.1
Sigsgaard, T.I.2
Kjaerulff, J.3
-
83
-
-
0024513524
-
Hum Familial mesothelioma: A report of two families
-
Hammar S.P., Bockus D., Remington F., Freidman S., LaZerte G. Hum Familial mesothelioma: a report of two families. Pathology. 20:1989;107-112.
-
(1989)
Pathology
, vol.20
, pp. 107-112
-
-
Hammar, S.P.1
Bockus, D.2
Remington, F.3
Freidman, S.4
Lazerte, G.5
-
84
-
-
0022479819
-
Familial clustering of mesothelioma: A report on three affected persons in one family
-
Krousel T., Garcas N., Rothschild H. Familial clustering of mesothelioma: a report on three affected persons in one family. Am. J. Prev. Med. 2:1986;186-188.
-
(1986)
Am. J. Prev. Med.
, vol.2
, pp. 186-188
-
-
Krousel, T.1
Garcas, N.2
Rothschild, H.3
-
86
-
-
0018821693
-
Familial clustering of malignant mesothelioma
-
Risberg B., Nickels J., Wagermark J. Familial clustering of malignant mesothelioma. Cancer. 45:1980;2422-2427.
-
(1980)
Cancer
, vol.45
, pp. 2422-2427
-
-
Risberg, B.1
Nickels, J.2
Wagermark, J.3
-
87
-
-
0021357401
-
Malignant mesothelioma in two pairs of siblings: Is there a hereditary predisposing factor?
-
Martensson G., Larsson S., Zettergren L. Malignant mesothelioma in two pairs of siblings: is there a hereditary predisposing factor? Eur. J. Respir. Dis. 65:1984;179-184.
-
(1984)
Eur. J. Respir. Dis.
, vol.65
, pp. 179-184
-
-
Martensson, G.1
Larsson, S.2
Zettergren, L.3
|